11/24
12:25 pm
cgem
Rating for CGEM
Medium
Report
Rating for CGEM
11/24
12:08 pm
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "buy" rating reaffirmed by analysts at BTIG Research.
High
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "buy" rating reaffirmed by analysts at BTIG Research.
11/20
11:08 pm
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.
11/20
11:08 pm
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.
9/12
08:03 am
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Low
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
9/11
08:08 am
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $32.00 price target on the stock.
Low
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $32.00 price target on the stock.